Connor, Clark & Lunn Investment Management (CC&L)
SGMO icon

Connor, Clark & Lunn Investment Management (CC&L)’s Sangamo Therapeutics SGMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-349,894
Closed -$1.1M 1432
2022
Q4
$1.1M Sell
349,894
-255,044
-42% -$801K 0.01% 679
2022
Q3
$2.96M Buy
604,938
+218,812
+57% +$1.07M 0.02% 419
2022
Q2
$1.6M Buy
386,126
+271,712
+237% +$1.13M 0.01% 515
2022
Q1
$665K Sell
114,414
-24,745
-18% -$144K ﹤0.01% 729
2021
Q4
$1.04M Sell
139,159
-150,869
-52% -$1.13M 0.01% 672
2021
Q3
$2.61M Buy
290,028
+105,116
+57% +$947K 0.01% 468
2021
Q2
$2.21M Buy
184,912
+94,506
+105% +$1.13M 0.01% 518
2021
Q1
$1.13M Sell
90,406
-46,857
-34% -$587K 0.01% 672
2020
Q4
$2.14M Buy
137,263
+119,470
+671% +$1.86M 0.01% 498
2020
Q3
$168K Buy
+17,793
New +$168K ﹤0.01% 852
2017
Q2
Sell
-55,509
Closed -$289K 930
2017
Q1
$289K Sell
55,509
-1,700
-3% -$8.85K ﹤0.01% 733
2016
Q4
$174K Sell
57,209
-12,900
-18% -$39.2K ﹤0.01% 805
2016
Q3
$325K Sell
70,109
-93,600
-57% -$434K ﹤0.01% 658
2016
Q2
$948K Sell
163,709
-123,100
-43% -$713K 0.01% 477
2016
Q1
$1.74M Sell
286,809
-70,700
-20% -$428K 0.01% 355
2015
Q4
$3.26M Buy
357,509
+74,625
+26% +$681K 0.03% 268
2015
Q3
$1.6M Buy
282,884
+179,312
+173% +$1.01M 0.01% 330
2015
Q2
$1.15M Sell
103,572
-23,100
-18% -$256K 0.01% 314
2015
Q1
$1.99M Sell
126,672
-10,500
-8% -$165K 0.02% 234
2014
Q4
$2.09M Buy
137,172
+88,672
+183% +$1.35M 0.02% 219
2014
Q3
$523K Buy
+48,500
New +$523K ﹤0.01% 382
2014
Q2
Sell
-53,400
Closed -$1.07M 620
2014
Q1
$1.07M Buy
53,400
+35,600
+200% +$711K 0.01% 371
2013
Q4
$263K Sell
17,800
-25,100
-59% -$371K ﹤0.01% 624
2013
Q3
$463K Buy
42,900
+18,700
+77% +$202K ﹤0.01% 376
2013
Q2
$199K Buy
+24,200
New +$199K ﹤0.01% 474